FTC Declares Victory in Generic Drug Case

June 17 (Bloomberg) -- Drugmakers can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

BlueCrest, Platt to Return Outside Investors' Money
45:30 - BlueCrest Capital Management will return all client money and focus on managing the wealth of co-founder Michael Platt and that of his employees and partners. Bloomberg's Stephanie Ruhle examines the move on "Bloomberg Markets." (Source: Bloomberg)
  • UBS’s Smiles Says Draghi Has Talked Himself Into a Corner
  • How Currencies Impact Global Monetary Policy
  • Keeping Boutique Firms Out of Regulators' Reach